D75.81

acute myelofibrosis (C94.4-) idiopathic myelofibrosis (D47.1) leukoerythroblastic anemia (D61.82) myelofibrosis with myeloid metaplasia (D47.4) myelophthisic anemia (D61.82) myelophthisis (D61.82) primary myelofibrosis (D47.1)

code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-) code for adverse effect, if applicable, to identify drug (T45.1X5)

the underlying disorder, such as: malignant neoplasm of breast (C50.-)

Myelofibrosis NOS Secondary myelofibrosis NOS

acute lymphadenitis (L04.-) chronic lymphadenitis (I88.1) enlarged lymph nodes (R59.-) hypergammaglobulinemia NOS (D89.2) lymphadenitis NOS (I88.9) mesenteric lymphadenitis (acute) (chronic) (I88.0)

autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)